Association between glycogen synthase kinase-3 beta gene polymorphisms and attention deficit hyperactivity disorder in Korean children: A preliminary study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shim, Se-Hoon | - |
dc.contributor.author | Hwangbo, Young | - |
dc.contributor.author | Kwon, Young-Joon | - |
dc.contributor.author | Lee, Hwa-Young | - |
dc.contributor.author | Kim, Ji-Hoon | - |
dc.contributor.author | Yoon, Ho-Kyoung | - |
dc.contributor.author | Hwang, Jung-A | - |
dc.contributor.author | Kim, Yong-Ku | - |
dc.date.accessioned | 2021-09-06T14:42:38Z | - |
dc.date.available | 2021-09-06T14:42:38Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2012-10-01 | - |
dc.identifier.issn | 0278-5846 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/107235 | - |
dc.description.abstract | Glycogen synthase kinase (GSK)-3 beta plays a key role in the phosphorylation and regulation of metabolic enzymes and many transcription factors. Recent studies have suggested the involvement of GSK-3 beta in the pathogenesis and treatment target of DA-associated neuropsychiatric disorders, which has led to consider GSK-beta as one of the candidate genes for those disorders. GSK-3 beta genes are likely to be involved in mechanisms underlying attention deficit hyperactivity disorder (ADHD). We investigated the association between - 1727A/T and - 50T/C SNPs of GSK-3 beta gene with ADHD. All ADHD subjects completed a comprehensive and standardized diagnostic test and psychological evaluation battery, including the parents' Korean version of the ADHD Rating Scale-IV (ARS). The genotype and allele frequencies of 103 ADHD patients and 173 normal controls were analyzed for - 1727A/T and - 50T/C SNPs of GSK-3 beta gene. There were statistically significant differences in the genotype distributions of the - 1727A/T SNP of GSK-3 beta gene between the ADHD group and the control group. The frequency of the genotype AT was significantly higher in the ADHD patients. Concerning the haplotype, there was a significant difference in the A-C haplotype frequency between the two samples. However, no differences in either the genotype distribution or in allele frequencies of - 50C/T were observed between the two samples. In the parents version of K-ARS of all subjects, ANCOVA revealed that two subscales and the total score were significantly higher in the subjects with AT + TT genotypes than those with AA genotype after adjusting for age and gender. The odds ratio for the ADHD patients was 1.79, comparing the AT genotype group with the AA genotype group. Therefore, genotype AT is associated with a higher risk of ADHD. Our results suggest that the - 1727A/T SNP of GSK-3 beta gene may affect susceptibility in ADHD. Further investigation with a larger number of subjects is needed to validate this finding. (c) 2012 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | ONSET ALZHEIMERS-DISEASE | - |
dc.subject | SEQUENCE VARIANTS | - |
dc.subject | SCHIZOPHRENIA | - |
dc.subject | KINASE | - |
dc.subject | MODEL | - |
dc.subject | PSYCHOSTIMULANTS | - |
dc.subject | IMMUNOREACTIVITY | - |
dc.subject | IDENTIFICATION | - |
dc.subject | GSK3-BETA | - |
dc.subject | BEHAVIOR | - |
dc.title | Association between glycogen synthase kinase-3 beta gene polymorphisms and attention deficit hyperactivity disorder in Korean children: A preliminary study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Ho-Kyoung | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Ku | - |
dc.identifier.doi | 10.1016/j.pnpbp.2012.05.008 | - |
dc.identifier.scopusid | 2-s2.0-84864499969 | - |
dc.identifier.wosid | 000308630200009 | - |
dc.identifier.bibliographicCitation | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, v.39, no.1, pp.57 - 61 | - |
dc.relation.isPartOf | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | - |
dc.citation.title | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | - |
dc.citation.volume | 39 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 57 | - |
dc.citation.endPage | 61 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | ONSET ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | SEQUENCE VARIANTS | - |
dc.subject.keywordPlus | SCHIZOPHRENIA | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordPlus | PSYCHOSTIMULANTS | - |
dc.subject.keywordPlus | IMMUNOREACTIVITY | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | GSK3-BETA | - |
dc.subject.keywordPlus | BEHAVIOR | - |
dc.subject.keywordAuthor | ADHD | - |
dc.subject.keywordAuthor | Attention deficit hyperactivity disorder | - |
dc.subject.keywordAuthor | Glycogen synthase kinase | - |
dc.subject.keywordAuthor | GSK-3 beta | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.